The Patent Finder

Terms ending in 2029

Baxalta Incorporated

Every in-force patent on Baxalta Incorporated's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,399,249Procedure for the Generation of a High Producer Cell Line for the Expression of a Recombinant ANTI-CD34 Antibody
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 10,233,436ADAMTS13-Containing Compositions Having Thrombolytic Activity
In force
 · Medium confidence
Takeda Pharmaceutical Company LimitedIn forceMedium confidence
US 9,206,234Biologically Active Peptides
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 10,287,319Biologically Active Peptides
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,399,632Method for the Purification of Recombinant Blood Coagulation Factor IX Enriched in Sulfated And/Or Phosphorylated Molecules
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,022,187Fviii-Independent Fix-Mutant Proteins for Hemophilia a Treatment
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 8,962,549Polymeric Benzyl Carbonate-Derivatives
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 10,232,022Lyophilized Recombinant VWF Formulations
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 10,512,674Factor VIII Formulations
In force
 · Medium confidence
Takeda Pharmaceutical Company LimitedIn forceMedium confidence
US 11,020,459Factor VIII Formulations
In force
 · Medium confidence
Takeda Pharmaceutical Company LimitedIn forceMedium confidence
6 more term ends in 2029 · Pro
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
Upgrade to Pro
1 of these is in force and held by Baxalta Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited